MFAP5 and neoplasm: Leung et al. showed that the CAF-derived factor, microfibrillar-associated protein 5 (MFAP5), increases the expression of lipoma-preferred partner in microvascular endothelial cells, leading to alterations in endothelial cell permeability and compromised paclitaxel delivery to tumor cells [252].